Emerging Biomarkers in Urological Cancers: Angiogenesis and Damage-Associated Molecular Pattern Signaling
International Journal of Molecular Sciences · 18.09.2025 · 26 (18) · 9130
DOI: 10.3390/ijms26189130 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.09.2025. Verfasst von Kacper Robert Karpiuk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Medical University of Białystok, 15-276 Białystok, Poland. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Urologic Neoplasms, Neovascularization, Pathologic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Bialystok.
Abstract (Originalsprache)
The interaction between tumor cells and stroma in urological malignancies is governed by secreted and damage-associated factors that promote angiogenesis, immune modulation, and metastasis. This review synthesizes current evidence on six biomarkers—GDF15, VEGF, TGF-β1, HSP90, HMGB1, and S100A9—detailing their biological functions and clinical implications. We discuss GDF15’s roles in metabolic stress and immune regulation, VEGF’s central role in neovascularization, and TGF-β1’s dualistic tumor-suppressive and promotive effects. We then examine damage-associated molecular patterns, highlighting HSP90’s extracellular immunomodulation, HMGB1’s signaling via pattern-recognition receptors, and S100A9’s pro-inflammatory activity through RAGE and Toll-like receptors. Comparative analyses across renal cell carcinoma and bladder cancer cohorts elucidate each marker’s diagnostic accuracy, prognostic value, and predictive capacity for targeted therapies. Notably, GDF15 and HSP90 correlate with ferroptosis susceptibility in RCC and urinary VEGF with HMGB1 increases the chances of non-invasive bladder cancer detection. We suggest that multiplexed biomarker panels could enhance early detection, risk stratification, and personalized treatment in urological oncology. We advocate for prospective studies to validate thresholds, clarify interactions, and improve clinical integration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Medical University of Białystok, 15-276 Białystok, Poland.
- Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, 15-269 Białystok, Poland.
ORCID-Profile: Kacper Robert Karpiuk, Grzegorz Młynarczyk, Joanna Matowicka-Karna
Förderung
- Medical University of Bialystok
Zitieren
APA
Karpiuk, K. R., Młynarczyk, G., Matowicka-Karna, J., & Darewicz, B. (2025). Emerging Biomarkers in Urological Cancers: Angiogenesis and Damage-Associated Molecular Pattern Signaling. International Journal of Molecular Sciences, 26(18), 9130. https://doi.org/10.3390/ijms26189130
Vancouver
Karpiuk KR, Młynarczyk G, Matowicka-Karna J, Darewicz B. Emerging Biomarkers in Urological Cancers: Angiogenesis and Damage-Associated Molecular Pattern Signaling. International Journal of Molecular Sciences. 2025;26(18):9130. doi:10.3390/ijms26189130
BibTeX
@article{Karpiuk2025,
author = {Karpiuk, Kacper Robert and Młynarczyk, Grzegorz and Matowicka-Karna, Joanna and Darewicz, Barbara},
title = {Emerging Biomarkers in Urological Cancers: Angiogenesis and Damage-Associated Molecular Pattern Signaling},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {18},
pages = {9130},
doi = {10.3390/ijms26189130}
}
EUVIMED